...
首页> 外文期刊>Journal of breath research >Breath volatile organic compounds of lung transplant recipients with and without chronic lung allograft dysfunction
【24h】

Breath volatile organic compounds of lung transplant recipients with and without chronic lung allograft dysfunction

机译:呼吸肺移植受者的挥发性有机化合物,无慢性肺同种异体移植功能障碍

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction. Chronic lung allograft dysfunction with its clinical correlative of bronchiolitis obliterans syndrome (BOS) remains the major limiting factor for long-term graft survival. Currently there are no established methods for the early diagnosis or prediction of BOS. To assess the feasibility of breath collection as a non-invasive tool and the potential of breath volatile organic compounds (VOC) for the early detection of BOS, we compared the breath VOC composition between transplant patients without and different stages of BOS. Methods. 75 outpatients (25 BOS stage 0, 25 BOS stage 1?+?2, 25 BOS stage 3) after bilateral lung transplantation were included. Exclusion criteria were active smoking, oxygen therapy and acute infection. Patients inhaled room air through a VOC and sterile filter and exhaled into an aluminum reservoir tube. Breath was loaded directly onto Tenax~? TA adsorption tubes and was subsequently analyzed by gas-chromatography/mass-spectrometry. Results. The three groups were age and gender matched, but differed with respect to time since transplantation, the spectrum of underlying disease, and treatment regimes. Relative to patients without BOS, BOS stage 3 patients showed a larger number of different VOCs, and more pronounced differences in the level of VOCs as compared to BOS stage 1?+?2 patients. Logistic regression analysis found no differences between controls and BOS 1?+?2, but four VOCs (heptane, isopropyl-myristate, ethyl-acetate, ionone) with a significant contribution to the discrimination between controls and BOS stage 3.A combination of these four VOCs separated these groups with an area under the curve of 0.87. Conclusion. Breath sample collection using our reservoir sampler in the clinical environment was feasible. Our results suggest that breath VOCs can discriminate severe BOS. However, convincing evidence for VOCs with a potential to detect early onset BOS is lacking.
机译:介绍。慢性肺同种异体移植功能障碍与支气管炎的临床相关性盲核酸综合征(BOS)仍然是长期移植存活的主要限制因素。目前,BOS的早期诊断或预测没有建立的方法。为了评估呼吸收集作为非侵入性工具的可行性以及用于早期检测博斯的呼吸挥发性有机化合物(VOC)的潜力,我们比较了移植患者之间的呼吸VOC组成而没有BOS的不同阶段。方法。包括在包含双侧肺移植后的75例外分筛(25 bos阶段0,25 bos阶段1?+ 2,25 bos阶段3)。排除标准是活跃的吸烟,氧疗法和急性感染。患者通过VOC和无菌过滤器吸入室内空气,并呼出到铝储层管中。呼吸直接加载到Tenax上〜? TA吸附管,随后通过气相色谱/质谱分析。结果。三组是年龄和性别匹配,但由于移植,潜在疾病的谱和治疗方案的时间不同。相对于没有BOS的患者,BOS阶段3患者显示出更多的不同VOC,并且与BOS第1阶段的VOCS水平更明显的差异?2名患者。 Logistic回归分析发现对照和BOS 1之间没有差异?+?2,但是四个VOC(庚烷,异丙基 - 肌号,乙酸乙酯,离子酮),对对照和BOS阶段的歧视有重大贡献。四个VOCS将这些组与0.87曲线下的区域分开。结论。使用我们的水库采样器在临床环境中使用呼吸样品收集是可行的。我们的结果表明,呼吸VOC可以歧视严重的博士。然而,缺乏令人信服VOC的证据,缺乏潜力检测早期发病BOS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号